Previous 10 | Next 10 |
Image source: The Motley Fool. Axonics Modulation Technlogs INC (NASDAQ: AXNX) Q3 2019 Earnings Call Nov 14, 2019 , 4:30 p.m. ET Operator Continue reading
Axonics Modulation Technologies, Inc. (AXNX) Q3 2019 Earnings Conference Call November 14, 2019 04:30 PM ET Company Participants Matt Clawson - Investor Relations, Practice Leader and Investor Relations at W2O Group Raymond Cohen - Chief Executive Officer Dan Dearen - President &...
Axonics Modulation Technologies (NASDAQ: AXNX ): Q3 GAAP EPS of -$0.89 misses by $0.15 . Revenue of $1.31M (+555.0% Y/Y) misses by $0.14M . Press Release More news on: Axonics Modulation Technologies, Inc., Earnings news and commentary, Healthcare stocks news,
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the thir...
Gainers: Astrotech Corporation (NASDAQ: ASTC ) +87% . More news on: Astrotech Corporation, Pier 1 Imports, Inc., Celsion Corporation, Stocks on the move, Read more ...
Shares of Axonics Modulation Technologies (NASDAQ: AXNX) , a medical device company focused on bladder and bowel dysfunction , rose 15% as of 11:00 a.m. EST on Thursday. The double-digit jump is a response to the news that the company won FDA approval for its Axonics r-SNM (rechargeable sacr...
Exicure (NASDAQ: XCUR ) +30% on collaboration with Allergan in hair loss disorders. More news on: Exicure, Inc., Opera Limited, Ping Identity Holding Corp., Stocks on the move, Read more ...
The FDA approves Axonics Modulation Technologies' (NASDAQ: AXNX ) Axonics r-SNM System for clinical indications of overactive bladder and urinary retention. More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable rechargeable sacral neuromodulation (“SNM”) devices for the treatment of bladder and bowel dysfunction, today announced the approval of ...
The following healthcare companies have filed for mixed shelf offerings: More news on: Cytokinetics, Incorporated, Twist Bioscience Corporation, Axonics Modulation Technologies, Inc., Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
Axonics Modulation Technologies Inc. Company Name:
AXNX Stock Symbol:
NASDAQ Market:
Axonics Modulation Technologies Inc. Website:
Viridien ADR (CGGYD) is expected to report for Q2 2024 Civitas Resources Inc. (CIVI) is expected to report $2.9 for Q2 2024 Aptiv PLC (APTV) is expected to report $1.37 for Q2 2024 Ardelyx Inc. (ARDX) is expected to report $-0.1 for Q2 2024 Beazer Homes USA Inc. (BZH) is expected ...
AstraZeneca PLC (AZN) is expected to report $0.97 for Q2 2024 BJ's Restaurants Inc. (BJRI) is expected to report $0.49 for Q2 2024 Baker Hughes Company (BKR) is expected to report $0.49 for Q2 2024 BlueHarbor Bank (BLHK) is expected to report for Q2 2024 Betterware de Mexico S.A.P...
2024-06-19 23:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...